Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer.
The collaboration...
PARIS & DIJON, France–(BUSINESS WIRE)–Regulatory News: Oncodesign (ALONC – FR0011766229), a biopharmaceutical group specializing in precision medicine, announced today the strengthening of its...
HOUSTON–(BUSINESS WIRE)–$KRBP #KRBP–Kiromic BioPharma, Inc. (Nasdaq: KRBP) (the “Company”), an immuno-oncology target discovery and gene-editing company with a proprietary artificial intelligence neural network...
New funding: Outpace Bio raised a $30 million Series A investment round to design custom cell and gene-based therapies.
The science: Founded in November,...